But what some people dont understand is that when they stop taking the medication, they may gain all that weight back. (The current study did not evaluate weight gain after the discontinuation of GLP-1 medications.) GLP-1 medications act as a pharmaceutical version of a natural hormone in the gut, lowering blood sugar, keeping you feeling fuller longer and slowing down digestion
Over time, however, the policy could push insurers toward broader coverage, increase access to future obesity drugs (including upcoming oral GLP-1s, like Orforglipron) , and put competitive pressure on manufacturers to reduce costs further
GSH injectables are not FDA-approved for skin lightening and carry more risks
The majority of respondents (67%) told the Business Group on Health that they do provide a way for employees to have the costs of drugs covered for weight losswhich has been the sticking point for Medicare and commercial health plans
(SW-04305A): Dateland Public Service Co., Inc